2 active not recruiting, 2 completed, 1 recruiting, 1 unknown. 5 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Active not recruiting 2, Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Vulvo Vaginal Atrophy: new trials by email Literature Review of Vulvo Vaginal Atrophy trials Research Report on Vulvo Vaginal Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| F-GYN for Vaginal Dryness and Vulvovaginal Atrophy F-GYN Non-Crosslinked Hyaluronic Acid Injectable Gel, Standard Non-Hormonal Symptomatic Care - Atrophic Vaginitis, Atrophic Vulvovaginitis | Not applicable | Recruiting | Biovico Sp. z o.o. | 130 | 2026-07-24 | 2026-10-01 |
| Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA) product: Innea Aqua vaginal use, arm 2: standard of care - Vulvo Vaginal Atrophy | Not applicable | Active not recruiting | Innate srl | 62 | 2025-09-25 | 2026-02-09 |
| Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment vaginal dilators - Vulvo Vaginal Atrophy, Genitourinary Syndrome of Menopause (GSM) | Not applicable | Unknown | Centre Hospitalier Universitaire Saint Pierre | 160 | 2024-10-16 | 2025-02-14 |
| Evaluation of the Performance and Safety of Hyalo Gyn® Gel Compared to Placebo in Postmenopausal Breast Cancer Survivors Hyalo Gyn Vaginal Gel, Placebo - Vulvo Vaginal Atrophy | Not applicable | Active not recruiting | Fidia Farmaceutici s.p.a. | 156 | 2024-08-01 | 2026-02-12 |
| Regenerative Treatment of Female Genital Atrophy Mesotherapy with Autologous Platelet-Rich Plasma (PRP) to vulvovaginal area, Mesotherapy with saline solution, Platelet-Poor Plasma Gel - Vulvo Vaginal Atrophy | Phase 1 / Phase 2 | Completed | AndreiaAntunes | 30 | 2024-06-04 | 2025-12-31 |
| A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy Femarelle - Vulvo Vaginal Atrophy | Not applicable | Completed | Dr. Lila Nachtigall Rapid Medical Research, New York | 12 | 2011-01-01 | 2017-03-20 |
Dyspareunia (2) · Atrophic Vaginitis (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Mental Disorders (2) · Sexual Dysfunction, Physiological (2) · Sexual Dysfunctions, Psychological (2) · Urogenital Diseases (2) · Vaginal Diseases (1) · Vaginitis (1)
DT56a (1) · Mesotherapy (1) · Saline Solution (1)
AndreiaAntunes (1) · Biovico Sp. z o.o. (1) · Centre Hospitalier Universitaire Saint Pierre (1) · Dr. Lila Nachtigall Rapid Medical Research, New York (1) · Fidia Farmaceutici s.p.a. (1) · Innate srl (1)
Belgium (1) · Italy (1) · Poland (1) · Portugal (1) · Romania (1) · United States (1)
Andreia R Antunes, PhD Student and Medical Doctor (1) · Cristina Isabel Nogueira-Silva, PhD, Medical Doctor (1) · Lila Nachtigall, MD (1) · Maria S Guarino, PhD (1) · Serge Rozenberg, Gynaecologist (1)